These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 30116734

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Slowly progressive insulin-dependent (type 1) diabetes positive for anti-GAD antibody ELISA test may be strongly associated with a future insulin-dependent state.
    Oikawa Y, Tanaka H, Uchida J, Atsumi Y, Osawa M, Katsuki T, Kawai T, Shimada A.
    Endocr J; 2017 Feb 27; 64(2):163-170. PubMed ID: 27760891
    [Abstract] [Full Text] [Related]

  • 3. Discrepancy of glutamic acid decarboxylase 65 autoantibody results between RSR radioimmunoassay and enzyme-linked immunosorbent assay in patients with type 1 diabetes is related to autoantibody affinity.
    Kawasaki E, Okada A, Uchida A, Fukuyama T, Sagara Y, Nakano Y, Tamai H, Tojikubo M, Koga N.
    J Diabetes Investig; 2019 Jul 27; 10(4):990-996. PubMed ID: 30582775
    [Abstract] [Full Text] [Related]

  • 4. Clinical and genetic characteristics of people with type 1 diabetes who have discrepancies in titers of anti-glutamic acid decarboxylase antibody measured by radioimmunoassay and enzyme-linked immunosorbent assay.
    Takagi S, Miura J, Hoshina S, Uchigata Y, Babazono T.
    J Diabetes Investig; 2020 Mar 27; 11(2):356-362. PubMed ID: 31267698
    [Abstract] [Full Text] [Related]

  • 5. Prediction of future insulin-deficiency in glutamic acid decarboxylase autoantibody enzyme-linked immunosorbent assay-positive patients with slowly-progressive type 1 diabetes.
    Kawasaki E, Awata T, Ikegami H, Imagawa A, Oikawa Y, Osawa H, Katsuki T, Kanatsuna N, Kawamura R, Kozawa J, Kodani N, Kobayashi T, Shimada A, Shimoda M, Takahashi K, Chujo D, Tsujimoto T, Tsuchiya K, Terakawa A, Terasaki J, Nagasawa K, Noso S, Fukui T, Horie I, Yasuda K, Yasuda H, Yanai H, Hanafusa T, Kajio H, Japanese Type 1 Diabetes Database Study (TIDE‐J).
    J Diabetes Investig; 2024 Jul 27; 15(7):835-842. PubMed ID: 38451108
    [Abstract] [Full Text] [Related]

  • 6. Bivalent GAD autoantibody ELISA improves clinical utility and risk prediction for adult autoimmune diabetes.
    Kawasaki E, Shimada A, Imagawa A, Abiru N, Awata T, Oikawa Y, Osawa H, Kawabata Y, Kozawa J, Kobayashi T, Takahashi K, Chujo D, Fukui T, Miura J, Yasuda K, Yasuda H, Kajio H, Hanafusa T, Ikegami H, Committee of type 1 diabetes, Japan Diabetes Society.
    J Diabetes Investig; 2023 Apr 27; 14(4):570-581. PubMed ID: 36691729
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A comparison of serum and EDTA plasma in the measurement of glutamic acid decarboxylase autoantibodies (GADA) and autoantibodies to islet antigen-2 (IA-2A) using the RSR radioimmunoassay (RIA) and enzyme linked immunosorbent assay (ELISA) kits.
    Rahmati K, Lernmark A, Becker C, Foltyn-Zadura A, Larsson K, Ivarsson SA, Törn C.
    Clin Lab; 2008 Apr 27; 54(7-8):227-35. PubMed ID: 18942490
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Gender differences in GAD antibody-positive diabetes mellitus in relation to age at onset, C-peptide and other endocrine autoimmune diseases.
    Lindholm E, Hallengren B, Agardh CD.
    Diabetes Metab Res Rev; 2004 Apr 27; 20(2):158-64. PubMed ID: 15037992
    [Abstract] [Full Text] [Related]

  • 11. High glutamic acid decarboxylase antibody titers may be associated with a decline in β-cell function over time and future insulin deficiency in latent autoimmune diabetes in adults.
    Haisa A, Oikawa Y, Satomura A, Suzuki S, Nakanishi S, Fujisawa M, Morita H, Katsuki T, Shimada A.
    Diabetes Res Clin Pract; 2024 Sep 27; 215():111799. PubMed ID: 39084295
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes.
    Buzzetti R, Di Pietro S, Giaccari A, Petrone A, Locatelli M, Suraci C, Capizzi M, Arpi ML, Bazzigaluppi E, Dotta F, Bosi E, Non Insulin Requiring Autoimmune Diabetes Study Group.
    Diabetes Care; 2007 Apr 27; 30(4):932-8. PubMed ID: 17392553
    [Abstract] [Full Text] [Related]

  • 16. High titre of antiglutamic acid decarboxylase autoantibody is a strong predictor of the development of thyroid autoimmunity in patients with type 1 diabetes and latent autoimmune diabetes in adults.
    Jin P, Huang G, Lin J, Yang L, Xiang B, Zhou W, Zhou Z.
    Clin Endocrinol (Oxf); 2011 May 27; 74(5):587-92. PubMed ID: 21470281
    [Abstract] [Full Text] [Related]

  • 17. Diagnostic accuracy of the anti-glutamic acid decarboxylase antibody in type 1 diabetes mellitus: Comparison between radioimmunoassay and enzyme-linked immunosorbent assay.
    Murata T, Tsuzaki K, Nirengi S, Watanabe T, Mizutani Y, Okada H, Tsukamoto M, Odori S, Nakagawachi R, Kawaguchi Y, Yoshioka F, Yamada K, Shimatsu A, Kotani K, Satoh-Asahara N, Sakane N.
    J Diabetes Investig; 2017 Jul 27; 8(4):475-479. PubMed ID: 27863109
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. High GADA titer increases the risk of insulin requirement in LADA patients: a 7-year follow-up (NIRAD study 7).
    Zampetti S, Campagna G, Tiberti C, Songini M, Arpi ML, De Simone G, Cossu E, Cocco L, Osborn J, Bosi E, Giorgino F, Spoletini M, Buzzetti R, NIRAD Study Group.
    Eur J Endocrinol; 2014 Dec 27; 171(6):697-704. PubMed ID: 25213702
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.